BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P3D REFRESH-INTERVAL:P3D CALSCALE:GREGORIAN BEGIN:VEVENT DTSTART:20190612T114500Z DTEND:20190612T131500Z X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:June Breakfast 2019 DESCRIPTION:Jupiter Medical Center Presentation by Dr. Bhagwandin\, on the latest surgical advancements utilizing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage abdominal cancer. \n\n\n\nThe American Cancer Society (National Cancer Institute concurs):\n\n By 2030\, colorectal cancer incidence rates will be up 90% in people between ages 20 and 34\, and 28% for people between ages 35 and 49. Lack of exercise\, diet\, obesity\, smoking\, and alcohol can raise the odds of having colon cancer at all ages\, and researchers are looking at all for potential causes.\n About 27\,510 cases of stomach cancer will be diagnosed in 2019. More women than men.\n Worldwide\, Liver cancer is one of the most common cancers more than half a million new cases reported each year considered third leading cause of cancer related death.\n Incidence of Liver and other GI cancers are on the rise in North America due to the obesity epidemic and the increased risk for developing nonalcoholic fatty liver disease.\n\n \n\nJupiter Medical Center announces the surgical skills of Dr. Bhagwandin\, being the first hospital on the east coast of Florida\, to perform Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage abdominal cancer. There are only a handful of surgeons nationally who have the skills to perform this procedure.\n\nHIPEC advantages over standard chemotherapy: \n\n\n It is a single treatment done in the operating room\, instead of multiple treatments over several weeks\n 90% of the drug stays within the abdominal cavity\, decreasing toxic effects on the rest of the body\n It allows for a more intense dose of chemotherapy\n\n Dr. Bhagwandin is a fellowship trained surgical oncologist and board certified general surgeon. His clinical and research interests include the diagnosis and treatment of complex malignancies of the liver\, pancreas\, and biliary tract\, in addition to gastric and esophageal cancer\, colon and rectal cancer\, sarcoma\, and melanoma. He delivers compassionate care with the goal of restoring patient well-being. \n\n \n\nHe also specializes in the management of advanced peritoneal carcinomatosis through the application of Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) and cytoreductive surgery\; a technique that combines surgery with chemotherapy delivered directly into the abdomen.\n\n \n\nMedical Appointments\n\nMedical Director\, Gastrointestinal Surgical Oncology Program\, Jupiter Medical Center\n\nMedical Director\, Surgical Oncology Network Development\, The Mount Sinai Hospital\, New York\n\nAssistant Professor\, Department of Surgery\, Division of Surgical Oncology\, The Icahn School of Medicine at Mount Sinai\, New York\n\n \n\nEducation\n\nMedical School: Lake Erie College of Osteopathic Medicine\n\nInternship: The Icahn School of Medicine at Mount Sinai\, New York\n\nResidency: The University of Illinois at Chicago\n\nFellowship: The Icahn School of Medicine at Mount Sinai\, New York\n\n \n\nBoard Certifications\n\nBoard-certified\, General Surgery\n\nBoard-certified\, Complex General Surgical Oncology\n\n \n\nProfessional Memberships\n\n\n Society of Surgical Oncology (SSO)\n Americas Hepato-Pancreato-Biliary Association (AHPBA)\n American College of Surgery (ACS) X-ALT-DESC;FMTTYPE=text/html:Jupiter Medical Center Presentation by \;Dr. Bhagwandin\, \;on the latest surgical advancements utilizing Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage abdominal cancer. \;
\n
\nThe American Cancer Society (National Cancer Institute concurs):\n\n \;
\nJupiter Medical Center announces the surgical skills of Dr. Bhagwandin\, being the first hospital on the east coast of Florida\, to perform Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat late stage abdominal cancer. \; There are only a handful of surgeons nationally who have the skills to perform this procedure.
\nHIPEC advantages over standard chemotherapy: \;\n\n\n \;Dr. Bhagwandin \;is a fellowship trained surgical oncologist and board certified general surgeon. His clinical and research interests include the diagnosis and treatment of complex malignancies of the liver\, pancreas\, and biliary tract\, in addition to gastric and esophageal cancer\, colon and rectal cancer\, sarcoma\, and melanoma. \; He delivers compassionate care with the goal of restoring patient well-being. \;
\n \;
\nHe also specializes in the management of advanced peritoneal carcinomatosis through the application of Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) and cytoreductive surgery\; a technique that combines surgery with chemotherapy delivered directly into the abdomen.
\n \;
\nMedical Appointments
\nMedical Director\, Gastrointestinal Surgical Oncology Program\, Jupiter Medical Center
\nMedical Director\, Surgical Oncology Network Development\, The Mount Sinai Hospital\, New York
\nAssistant Professor\, Department of Surgery\, Division of Surgical Oncology\, The Icahn School of Medicine at Mount Sinai\, New York
\n \;
\nEducation
\nMedical School: Lake Erie College of Osteopathic Medicine
\nInternship: The Icahn School of Medicine at Mount Sinai\, New York
\nResidency: The University of Illinois at Chicago
\nFellowship: The Icahn School of Medicine at Mount Sinai\, New York
\n \;
\nBoard Certifications
\nBoard-certified\, General Surgery
\nBoard-certified\, Complex General Surgical Oncology
\n \;
\nProfessional Memberships\n\n\n LOCATION:Palm Beach County Convention Center 650 Okeechobee Blvd. West Palm Beach\, Florida 33401 UID:e.1455.25730 SEQUENCE:3 DTSTAMP:20260517T150637Z URL:https://dev.palmbeaches.org/events/details/june-breakfast-2019-25730 END:VEVENT END:VCALENDAR